Log In
BCIQ
Print this Print this
 

MAGE A10 TCR, MAGE-A10 SPEAR T-cell therapy

Also known as: MAGEA10 TCR

  Manage Alerts
Collapse Summary General Information
Company Adaptimmune Therapeutics plc
DescriptionT cell receptors targeting melanoma-associated antigen A10 (MAGEA10)
Molecular Target Melanoma-associated antigen A10 (MAGEA10)
Mechanism of Action 
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today